SlideShare a Scribd company logo
Atrial Fibrillation: Rate/Rhythm Control
  Non Pharmacological Management


              Dr Akshay Mehta
               Dr B Nanavati Hospital
                Asian Heart Institute
Two most important things to know


 Type of AF



Symptoms due to AF
First Diagnosed Episode of AF




Paroxysmal        Persistent (> 7   Long standing   Permanent
(usually          days or           Persistent      (accepted)
<= 48 h)          requires CV)      ( >1 year)
EHRA score of AF-related
                   symptoms

EHRA class               Explanation

EHRA I                   ‘No symptoms’

EHRA II                  ‘Mild symptoms’; normal daily activity not
                         affected

EHRA III                 ‘Severe symptoms’; normal daily activity
                         affected

EHRA IV                  ‘Disabling symptoms’; normal daily activity
                         discontinued
Choosing Rate v/s Rhythm Control

Two types of settings

Acute/Unstable

Non acute/Stable
Acute/Unstable setting
Rate Control                          Rhythm Control


Cause: underlying cond                 severe AF Sx or
Ex- pneumonia, PE, Thyroid           h-dynamic instab

No severe AF Sx or
h-dynamic instab             pharmac cv            electric cv

Older age

Large LA
How Rate
Control ?
Acute/Unstable setting
        Rhythm control – (Sx or hemody instab)

     Pharmac cv              Electrical cv

* <48 hrs                    *can > 48 hrs
* No electrolyte             *ischemia
  imbalance                  *hypoten
* No ECG                     *HF
   sign of severe            *Preexcited AF with
  ongoing ishemia              instability
* Hemodynamic stable + , -
ESC 2012
Recommendations for
anticoagulation pericardioversion
………..recommendations for
anticoagulation pericardioversion
Non Acute/Stable Setting :


Rate Control     v/s Rhythm control

               INCLUDES RATE CONTROL


         OAC for Both
AIMS of management of AF
                 patients:
• Prevent complications

• Reduce symptoms (palpitations, dyspnoea,
  fatigue, and dizziness)

 antithrombotic therapy
 control of ventricular rate
 Rx of associated CV disease


• ± Additional rhythm control therapy by
  cardioversion, antiarrhythmic drug therapy, or
  ablation therapy
Randomized trials comparing rate
     control with rhythm control
• Atrial Fibrillation Follow-up Investigation of Rhythm
   Management (AFFIRM) : no difference in all cause mortality
   (primary outcome) or stroke rate
• The Rate Control versus Electrical cardioversion for persistent
   atrial fibrillation (RACE) trial :rate control not inferior to rhythm
   control for prevention of cardiovascular mortality and morbidity
   (composite endpoint).
• The Atrial Fibrillation and Congestive Heart Failure
  (AF-CHF) trial : in patients with an LVEF ≤35%, no difference in
   cardiovascular mortality (primary outcome) symptoms
   of congestive heart failure, or in the secondary outcomes
   including death from any cause and worsening of heart failure
However….
• These studies enrolled predominantly older patients (average
  70 y)

• Most of whom had persistent AF and heart disease,

• Follow-up extended over just a few years

• Pts were at a stage where difficult to maintain sinus rhythm

 Hence :

• Data don’t necessarily apply in young

• Must not lose “window” of opportunity due to electrical and
  structural remodeling
Hence…
 Rate control may be reasonable initial therapy in
  older patients with persistent AF with mild
  symptoms

 For younger individuals, especially those with
  paroxysmal lone AF, rhythm control may be a better
  initial approach.
When to do Rate Control ?
How to do long-term rate control
How MUCH rate control ?


                              < 80, 110               Exercise test if
                                                  excessive heart rate
                                                  is anticipated during
                               More strict rate          exercise
           Symptoms               control
 Rate
Control                                           24 h ECG for safety
          No or tolerable      Accept lenient
            symptoms            rate control

                            resting<110/mt
Rhythm Control


  Rhythm control therapy is reasonable to
ameliorate symptoms, in paroxysmal/persistent
                    AF
When to do Rhythm Control ?
AAD Therapy to maintain sinus rhythm in
patients with recurrent paroxysmal or persistent
                atrial fibrillation.




                                 β-Blockers are recommended for prevention
                                 of adrenergic AF-I C & should be considered
                                 for rhythm (+ rate) control in a first episode
                                 of AF - IIa

                             2011 Writing Group Members et al. Circulation
                                          2011;123:104-123
                                    Copyright © American Heart Association
Antiarrhythmic drugs v/s left atrial ablation
     for rhythm control in AF ESC 2012
Catheter ablation for AF using the CARTO contact
                mapping system
Recommendations for surgical
      ablation of AF
Recommendations for LAA
closure/occlusion/excision - ESC 2012
Recommendation for atrioventricular
     node ablation in AF patients
Should be considered
 When the rate cannot be controlled with pharmacological agents and
 when AF cannot be prevented by antiarrhythmic therapy or is
  associated with intolerable side effects,
 when direct catheter-based or surgical ablation of AF is not indicated,
  has failed, or is rejected. IIa
Should be considered for patients with permanent AF and an indication
  for CRT (IIa)
Should be considered for CRT nonresponders in whom AF prevents
  effective biventricular stimulation and amiodarone is ineffective or
  contraindicated- IIa
• In patients with any type of AF and severely depressed LV function
  biventricular stimulation should be considered after AV node
  ablation.
Summary- management of patients with
      recurrent paroxysmal AF
              Recurrent Paroxysmal AF


        Minimal or no           Disabling
         symptoms            symptoms in AF


         Anticoagulation     Anticoagulation
        and rate control*    and rate control
           as needed           as needed



          No drug for         AAD therapy *
         prevention of
              AF
                            AF ablation if AAD
                             treatment fails
Summary- management of patients with recurrent
         persistent or permanent AF
                                              Recurrent Persistent AF                          Permanent AF


                                      Minimal or no                 Disabling              Anticoagulation and rate
                                       symptoms                                              control* as needed
                                                                 symptoms in AF

                                       Anticoagulation and     Anticoagulation and
                                         rate control* as          rate control
                                             needed

                                                               AAD drug therapy


                                                             Electrical cardioversion as
                                                                       needed


                                    Continuous anticoagulation as
                                   needed and therapy to maintain
                                           sinus rhythm *

    Consider ablation for severely symptomatic
 recurrent AF after failure of greater than or equal
            to 1 AAD plus rate control
THANK YOU!!!

More Related Content

What's hot

Cardiac pacemakers part ii
Cardiac pacemakers part iiCardiac pacemakers part ii
Cardiac pacemakers part ii
salah_atta
 
Basic pacing concepts
Basic pacing conceptsBasic pacing concepts
Basic pacing concepts
Nizam Uddin
 
Non infarction Q waves
Non infarction Q wavesNon infarction Q waves
Non infarction Q waves
Aby Thankachan
 
Atrial Fibrillation
Atrial FibrillationAtrial Fibrillation
Atrial Fibrillation
Summit Health
 
Bradyarrhythmias
BradyarrhythmiasBradyarrhythmias
Bradyarrhythmias
Abraham Paul
 
Cardiac arrythmias
Cardiac arrythmiasCardiac arrythmias
Cardiac arrythmias
Orhan Hakli
 
Atrial fibrillation management
Atrial fibrillation managementAtrial fibrillation management
Atrial fibrillation managementBasem Enany
 
Mechanism of arrythmias
Mechanism of arrythmiasMechanism of arrythmias
Mechanism of arrythmias
Sachin Sondhi
 
Cardiac Arrhythmias
Cardiac ArrhythmiasCardiac Arrhythmias
Cardiac Arrhythmias
Kathiri Venkat
 
Narrow complex tachycardia
Narrow complex tachycardiaNarrow complex tachycardia
Narrow complex tachycardia
Domina Petric
 
IDIOPATHIC VT
IDIOPATHIC VTIDIOPATHIC VT
IDIOPATHIC VT
Dharam Prakash Saran
 
Echocardiographic Evaluation of LV Diastolic Function
Echocardiographic Evaluation of LV Diastolic FunctionEchocardiographic Evaluation of LV Diastolic Function
Echocardiographic Evaluation of LV Diastolic Function
Junhao Koh
 
Acute coronary syndrome ppt
Acute coronary syndrome pptAcute coronary syndrome ppt
Acute coronary syndrome ppt
Dalia Zaafar
 
Atrial fibrillation ksaus hs 2019
Atrial fibrillation ksaus hs 2019Atrial fibrillation ksaus hs 2019
Atrial fibrillation ksaus hs 2019
hospital
 
Updates in management of Acute coronary syndrome
Updates in management of Acute coronary syndromeUpdates in management of Acute coronary syndrome
Updates in management of Acute coronary syndrome
Sanjeev K Agarwal
 
Narrow Complex Tachycardia
Narrow Complex TachycardiaNarrow Complex Tachycardia
Narrow Complex Tachycardia
Ahmed Ammar
 
Introduction to Electrophysiology - Supraventricular Tachycardias (1/4 lectures)
Introduction to Electrophysiology - Supraventricular Tachycardias (1/4 lectures)Introduction to Electrophysiology - Supraventricular Tachycardias (1/4 lectures)
Introduction to Electrophysiology - Supraventricular Tachycardias (1/4 lectures)
Jose Osorio
 
Atrial fibrillation
Atrial fibrillation Atrial fibrillation
Atrial fibrillation
Debojyoti Sarkar
 
Wide complex tacycardia
Wide complex tacycardiaWide complex tacycardia
Wide complex tacycardia
Kush Bhagat
 

What's hot (20)

Cardiac pacemakers part ii
Cardiac pacemakers part iiCardiac pacemakers part ii
Cardiac pacemakers part ii
 
Basic pacing concepts
Basic pacing conceptsBasic pacing concepts
Basic pacing concepts
 
Non infarction Q waves
Non infarction Q wavesNon infarction Q waves
Non infarction Q waves
 
Atrial Fibrillation
Atrial FibrillationAtrial Fibrillation
Atrial Fibrillation
 
Bradyarrhythmias
BradyarrhythmiasBradyarrhythmias
Bradyarrhythmias
 
Cardiac arrythmias
Cardiac arrythmiasCardiac arrythmias
Cardiac arrythmias
 
Atrial fibrillation management
Atrial fibrillation managementAtrial fibrillation management
Atrial fibrillation management
 
Mechanism of arrythmias
Mechanism of arrythmiasMechanism of arrythmias
Mechanism of arrythmias
 
Cabana
CabanaCabana
Cabana
 
Cardiac Arrhythmias
Cardiac ArrhythmiasCardiac Arrhythmias
Cardiac Arrhythmias
 
Narrow complex tachycardia
Narrow complex tachycardiaNarrow complex tachycardia
Narrow complex tachycardia
 
IDIOPATHIC VT
IDIOPATHIC VTIDIOPATHIC VT
IDIOPATHIC VT
 
Echocardiographic Evaluation of LV Diastolic Function
Echocardiographic Evaluation of LV Diastolic FunctionEchocardiographic Evaluation of LV Diastolic Function
Echocardiographic Evaluation of LV Diastolic Function
 
Acute coronary syndrome ppt
Acute coronary syndrome pptAcute coronary syndrome ppt
Acute coronary syndrome ppt
 
Atrial fibrillation ksaus hs 2019
Atrial fibrillation ksaus hs 2019Atrial fibrillation ksaus hs 2019
Atrial fibrillation ksaus hs 2019
 
Updates in management of Acute coronary syndrome
Updates in management of Acute coronary syndromeUpdates in management of Acute coronary syndrome
Updates in management of Acute coronary syndrome
 
Narrow Complex Tachycardia
Narrow Complex TachycardiaNarrow Complex Tachycardia
Narrow Complex Tachycardia
 
Introduction to Electrophysiology - Supraventricular Tachycardias (1/4 lectures)
Introduction to Electrophysiology - Supraventricular Tachycardias (1/4 lectures)Introduction to Electrophysiology - Supraventricular Tachycardias (1/4 lectures)
Introduction to Electrophysiology - Supraventricular Tachycardias (1/4 lectures)
 
Atrial fibrillation
Atrial fibrillation Atrial fibrillation
Atrial fibrillation
 
Wide complex tacycardia
Wide complex tacycardiaWide complex tacycardia
Wide complex tacycardia
 

Similar to Atrial Fibrillation: Rate/ Rhythm control-Non pharmacological management

Atrial fibrilation
Atrial fibrilationAtrial fibrilation
Atrial fibrilation
Dr.Rania Ismail Deeb Elashker
 
2016 ESC Guidelines Patient Leaflet Folder.pdf
2016 ESC Guidelines Patient Leaflet Folder.pdf2016 ESC Guidelines Patient Leaflet Folder.pdf
2016 ESC Guidelines Patient Leaflet Folder.pdf
QueenieCuaro1
 
Atrial fibrillation: rate or ryhthm?
Atrial fibrillation: rate or ryhthm?Atrial fibrillation: rate or ryhthm?
Atrial fibrillation: rate or ryhthm?Basem Enany
 
Atrial Fibrillation-Detection and management
Atrial Fibrillation-Detection and managementAtrial Fibrillation-Detection and management
Atrial Fibrillation-Detection and management
Sanjeev K Agarwal
 
Perioperative AF
Perioperative AFPerioperative AF
Perioperative AF
samaresh Drsamareshdas
 
Artrial fibrillation classification & management guideline
Artrial fibrillation classification & management guidelineArtrial fibrillation classification & management guideline
Artrial fibrillation classification & management guideline
Dr. Rohan Sonawane
 
Supra ventricular tachycardia
Supra ventricular tachycardiaSupra ventricular tachycardia
Supra ventricular tachycardiaTamil Mani
 
MANAGEMENT OF ATRIAL FIBRILLATION.pptx
MANAGEMENT OF ATRIAL FIBRILLATION.pptxMANAGEMENT OF ATRIAL FIBRILLATION.pptx
MANAGEMENT OF ATRIAL FIBRILLATION.pptx
JagtishViramuthu
 
Approach to tachyarrhythmia
Approach to tachyarrhythmiaApproach to tachyarrhythmia
Approach to tachyarrhythmia
KTD Priyadarshani
 
Atrial fibrillation
Atrial  fibrillation Atrial  fibrillation
Atrial fibrillation
SMSRAZA
 
Atrial fibrillation
Atrial  fibrillation Atrial  fibrillation
Atrial fibrillation
Syed Raza
 
Esc guideline for atrial fibrillation 2020 [dr pranab]
Esc guideline for atrial fibrillation 2020 [dr pranab]Esc guideline for atrial fibrillation 2020 [dr pranab]
Esc guideline for atrial fibrillation 2020 [dr pranab]
PranabanandaPal1
 
ATRIAL FIBRILLATION 2016
ATRIAL FIBRILLATION 2016ATRIAL FIBRILLATION 2016
ATRIAL FIBRILLATION 2016
Ravikanth Moka
 
Atrial Fibrillation by Dr. Aryan
Atrial Fibrillation by Dr. AryanAtrial Fibrillation by Dr. Aryan
Atrial Fibrillation by Dr. Aryan
Dr. Aryan (Anish Dhakal)
 
atrial fibrallition.ppt
atrial fibrallition.pptatrial fibrallition.ppt
atrial fibrallition.ppt
manojyadav409766
 
atrial fibrillation- management
atrial fibrillation- management atrial fibrillation- management
atrial fibrillation- management
amish117
 
A fib
A fibA fib
A fib
drralph123
 
Show notes
Show notesShow notes
Show notesGromimd
 
Persistent Atrial Fibrillation Management: Case preventation
Persistent Atrial Fibrillation Management: Case preventationPersistent Atrial Fibrillation Management: Case preventation
Persistent Atrial Fibrillation Management: Case preventationsalah_atta
 

Similar to Atrial Fibrillation: Rate/ Rhythm control-Non pharmacological management (20)

Dr. Sharma 2
Dr. Sharma 2Dr. Sharma 2
Dr. Sharma 2
 
Atrial fibrilation
Atrial fibrilationAtrial fibrilation
Atrial fibrilation
 
2016 ESC Guidelines Patient Leaflet Folder.pdf
2016 ESC Guidelines Patient Leaflet Folder.pdf2016 ESC Guidelines Patient Leaflet Folder.pdf
2016 ESC Guidelines Patient Leaflet Folder.pdf
 
Atrial fibrillation: rate or ryhthm?
Atrial fibrillation: rate or ryhthm?Atrial fibrillation: rate or ryhthm?
Atrial fibrillation: rate or ryhthm?
 
Atrial Fibrillation-Detection and management
Atrial Fibrillation-Detection and managementAtrial Fibrillation-Detection and management
Atrial Fibrillation-Detection and management
 
Perioperative AF
Perioperative AFPerioperative AF
Perioperative AF
 
Artrial fibrillation classification & management guideline
Artrial fibrillation classification & management guidelineArtrial fibrillation classification & management guideline
Artrial fibrillation classification & management guideline
 
Supra ventricular tachycardia
Supra ventricular tachycardiaSupra ventricular tachycardia
Supra ventricular tachycardia
 
MANAGEMENT OF ATRIAL FIBRILLATION.pptx
MANAGEMENT OF ATRIAL FIBRILLATION.pptxMANAGEMENT OF ATRIAL FIBRILLATION.pptx
MANAGEMENT OF ATRIAL FIBRILLATION.pptx
 
Approach to tachyarrhythmia
Approach to tachyarrhythmiaApproach to tachyarrhythmia
Approach to tachyarrhythmia
 
Atrial fibrillation
Atrial  fibrillation Atrial  fibrillation
Atrial fibrillation
 
Atrial fibrillation
Atrial  fibrillation Atrial  fibrillation
Atrial fibrillation
 
Esc guideline for atrial fibrillation 2020 [dr pranab]
Esc guideline for atrial fibrillation 2020 [dr pranab]Esc guideline for atrial fibrillation 2020 [dr pranab]
Esc guideline for atrial fibrillation 2020 [dr pranab]
 
ATRIAL FIBRILLATION 2016
ATRIAL FIBRILLATION 2016ATRIAL FIBRILLATION 2016
ATRIAL FIBRILLATION 2016
 
Atrial Fibrillation by Dr. Aryan
Atrial Fibrillation by Dr. AryanAtrial Fibrillation by Dr. Aryan
Atrial Fibrillation by Dr. Aryan
 
atrial fibrallition.ppt
atrial fibrallition.pptatrial fibrallition.ppt
atrial fibrallition.ppt
 
atrial fibrillation- management
atrial fibrillation- management atrial fibrillation- management
atrial fibrillation- management
 
A fib
A fibA fib
A fib
 
Show notes
Show notesShow notes
Show notes
 
Persistent Atrial Fibrillation Management: Case preventation
Persistent Atrial Fibrillation Management: Case preventationPersistent Atrial Fibrillation Management: Case preventation
Persistent Atrial Fibrillation Management: Case preventation
 

More from cardiositeindia

NSTEMI Invasive Treatment: Rationale and Timing
NSTEMI Invasive Treatment: Rationale and TimingNSTEMI Invasive Treatment: Rationale and Timing
NSTEMI Invasive Treatment: Rationale and Timing
cardiositeindia
 
Statins for primary prevention in Indians
Statins for primary prevention in IndiansStatins for primary prevention in Indians
Statins for primary prevention in Indians
cardiositeindia
 
How to choose drugs in pulmonary arterial hypertension
How to choose drugs in pulmonary arterial hypertensionHow to choose drugs in pulmonary arterial hypertension
How to choose drugs in pulmonary arterial hypertension
cardiositeindia
 
Home based oxygen therapy for severe pulmonary hypertension
Home based oxygen therapy for severe pulmonary hypertensionHome based oxygen therapy for severe pulmonary hypertension
Home based oxygen therapy for severe pulmonary hypertension
cardiositeindia
 
Choosing antiplatelet therapy before during and after hosp for acs
Choosing antiplatelet therapy before during and after hosp for acsChoosing antiplatelet therapy before during and after hosp for acs
Choosing antiplatelet therapy before during and after hosp for acs
cardiositeindia
 
Benefits of hypertension control
Benefits of hypertension controlBenefits of hypertension control
Benefits of hypertension control
cardiositeindia
 
Coronary CTA: The test of choice for obstructive CAD.
Coronary CTA: The test of choice for obstructive CAD.Coronary CTA: The test of choice for obstructive CAD.
Coronary CTA: The test of choice for obstructive CAD.
cardiositeindia
 
Investigating stable IHD- Treadmill, Dobutamine stress echo or Stress thallium
Investigating stable IHD- Treadmill, Dobutamine stress echo or Stress thalliumInvestigating stable IHD- Treadmill, Dobutamine stress echo or Stress thallium
Investigating stable IHD- Treadmill, Dobutamine stress echo or Stress thallium
cardiositeindia
 
What to choose in stable CAD- Medical therapy only or PCI or CABG?
What to choose in stable CAD- Medical therapy only or PCI or CABG?What to choose in stable CAD- Medical therapy only or PCI or CABG?
What to choose in stable CAD- Medical therapy only or PCI or CABG?
cardiositeindia
 
Coronary artery disease in indians: Glimpses from Indian data.
Coronary artery disease in indians: Glimpses from Indian data.Coronary artery disease in indians: Glimpses from Indian data.
Coronary artery disease in indians: Glimpses from Indian data.
cardiositeindia
 
Beta blockers in SIHD: Yes, all patients should receive them !
Beta blockers in SIHD: Yes, all patients should receive them !Beta blockers in SIHD: Yes, all patients should receive them !
Beta blockers in SIHD: Yes, all patients should receive them !
cardiositeindia
 
Beta blockers in sihd
Beta blockers in sihdBeta blockers in sihd
Beta blockers in sihd
cardiositeindia
 
Stable ischemic heart disease how is it different from acs..
Stable ischemic heart disease how is it different from acs..Stable ischemic heart disease how is it different from acs..
Stable ischemic heart disease how is it different from acs..
cardiositeindia
 
Mild heart failure (nyha i and ii) patients should not receive crt
Mild heart failure (nyha i and ii) patients should not receive crtMild heart failure (nyha i and ii) patients should not receive crt
Mild heart failure (nyha i and ii) patients should not receive crtcardiositeindia
 
All patients 40 days post mi should receive icd
All patients 40 days post mi should receive icdAll patients 40 days post mi should receive icd
All patients 40 days post mi should receive icd
cardiositeindia
 
Acute rv failure physiology to management
Acute rv failure  physiology to managementAcute rv failure  physiology to management
Acute rv failure physiology to managementcardiositeindia
 
Hypertension guidelines ESH ESC 2013
Hypertension guidelines ESH ESC 2013Hypertension guidelines ESH ESC 2013
Hypertension guidelines ESH ESC 2013cardiositeindia
 

More from cardiositeindia (20)

NSTEMI Invasive Treatment: Rationale and Timing
NSTEMI Invasive Treatment: Rationale and TimingNSTEMI Invasive Treatment: Rationale and Timing
NSTEMI Invasive Treatment: Rationale and Timing
 
Statins for primary prevention in Indians
Statins for primary prevention in IndiansStatins for primary prevention in Indians
Statins for primary prevention in Indians
 
How to choose drugs in pulmonary arterial hypertension
How to choose drugs in pulmonary arterial hypertensionHow to choose drugs in pulmonary arterial hypertension
How to choose drugs in pulmonary arterial hypertension
 
Home based oxygen therapy for severe pulmonary hypertension
Home based oxygen therapy for severe pulmonary hypertensionHome based oxygen therapy for severe pulmonary hypertension
Home based oxygen therapy for severe pulmonary hypertension
 
Choosing antiplatelet therapy before during and after hosp for acs
Choosing antiplatelet therapy before during and after hosp for acsChoosing antiplatelet therapy before during and after hosp for acs
Choosing antiplatelet therapy before during and after hosp for acs
 
Benefits of hypertension control
Benefits of hypertension controlBenefits of hypertension control
Benefits of hypertension control
 
Coronary CTA: The test of choice for obstructive CAD.
Coronary CTA: The test of choice for obstructive CAD.Coronary CTA: The test of choice for obstructive CAD.
Coronary CTA: The test of choice for obstructive CAD.
 
Investigating stable IHD- Treadmill, Dobutamine stress echo or Stress thallium
Investigating stable IHD- Treadmill, Dobutamine stress echo or Stress thalliumInvestigating stable IHD- Treadmill, Dobutamine stress echo or Stress thallium
Investigating stable IHD- Treadmill, Dobutamine stress echo or Stress thallium
 
What to choose in stable CAD- Medical therapy only or PCI or CABG?
What to choose in stable CAD- Medical therapy only or PCI or CABG?What to choose in stable CAD- Medical therapy only or PCI or CABG?
What to choose in stable CAD- Medical therapy only or PCI or CABG?
 
Coronary artery disease in indians: Glimpses from Indian data.
Coronary artery disease in indians: Glimpses from Indian data.Coronary artery disease in indians: Glimpses from Indian data.
Coronary artery disease in indians: Glimpses from Indian data.
 
Beta blockers in SIHD: Yes, all patients should receive them !
Beta blockers in SIHD: Yes, all patients should receive them !Beta blockers in SIHD: Yes, all patients should receive them !
Beta blockers in SIHD: Yes, all patients should receive them !
 
Beta blockers in sihd
Beta blockers in sihdBeta blockers in sihd
Beta blockers in sihd
 
Stable ischemic heart disease how is it different from acs..
Stable ischemic heart disease how is it different from acs..Stable ischemic heart disease how is it different from acs..
Stable ischemic heart disease how is it different from acs..
 
Mild heart failure (nyha i and ii) patients should not receive crt
Mild heart failure (nyha i and ii) patients should not receive crtMild heart failure (nyha i and ii) patients should not receive crt
Mild heart failure (nyha i and ii) patients should not receive crt
 
All patients 40 days post mi should receive icd
All patients 40 days post mi should receive icdAll patients 40 days post mi should receive icd
All patients 40 days post mi should receive icd
 
Sudden cardiac death
Sudden cardiac deathSudden cardiac death
Sudden cardiac death
 
Acute rv failure physiology to management
Acute rv failure  physiology to managementAcute rv failure  physiology to management
Acute rv failure physiology to management
 
Statin combinations
Statin combinationsStatin combinations
Statin combinations
 
Hypertension guidelines ESH ESC 2013
Hypertension guidelines ESH ESC 2013Hypertension guidelines ESH ESC 2013
Hypertension guidelines ESH ESC 2013
 
Anticoagulation in pci
Anticoagulation in pciAnticoagulation in pci
Anticoagulation in pci
 

Recently uploaded

POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyayaCharaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Dr KHALID B.M
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
Sujoy Dasgupta
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
Catherine Liao
 
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in StockFactory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
rebeccabio
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
MedicoseAcademics
 
Surgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptxSurgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptx
jval Landero
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 

Recently uploaded (20)

POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyayaCharaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
 
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in StockFactory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
 
Surgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptxSurgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptx
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 

Atrial Fibrillation: Rate/ Rhythm control-Non pharmacological management

  • 1. Atrial Fibrillation: Rate/Rhythm Control Non Pharmacological Management Dr Akshay Mehta Dr B Nanavati Hospital Asian Heart Institute
  • 2. Two most important things to know  Type of AF Symptoms due to AF
  • 3. First Diagnosed Episode of AF Paroxysmal Persistent (> 7 Long standing Permanent (usually days or Persistent (accepted) <= 48 h) requires CV) ( >1 year)
  • 4. EHRA score of AF-related symptoms EHRA class Explanation EHRA I ‘No symptoms’ EHRA II ‘Mild symptoms’; normal daily activity not affected EHRA III ‘Severe symptoms’; normal daily activity affected EHRA IV ‘Disabling symptoms’; normal daily activity discontinued
  • 5. Choosing Rate v/s Rhythm Control Two types of settings Acute/Unstable Non acute/Stable
  • 6. Acute/Unstable setting Rate Control Rhythm Control Cause: underlying cond severe AF Sx or Ex- pneumonia, PE, Thyroid h-dynamic instab No severe AF Sx or h-dynamic instab pharmac cv electric cv Older age Large LA
  • 8. Acute/Unstable setting Rhythm control – (Sx or hemody instab) Pharmac cv Electrical cv * <48 hrs *can > 48 hrs * No electrolyte *ischemia imbalance *hypoten * No ECG *HF sign of severe *Preexcited AF with ongoing ishemia instability * Hemodynamic stable + , -
  • 12. Non Acute/Stable Setting : Rate Control v/s Rhythm control INCLUDES RATE CONTROL OAC for Both
  • 13. AIMS of management of AF patients: • Prevent complications • Reduce symptoms (palpitations, dyspnoea, fatigue, and dizziness)  antithrombotic therapy  control of ventricular rate  Rx of associated CV disease • ± Additional rhythm control therapy by cardioversion, antiarrhythmic drug therapy, or ablation therapy
  • 14. Randomized trials comparing rate control with rhythm control • Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) : no difference in all cause mortality (primary outcome) or stroke rate • The Rate Control versus Electrical cardioversion for persistent atrial fibrillation (RACE) trial :rate control not inferior to rhythm control for prevention of cardiovascular mortality and morbidity (composite endpoint). • The Atrial Fibrillation and Congestive Heart Failure (AF-CHF) trial : in patients with an LVEF ≤35%, no difference in cardiovascular mortality (primary outcome) symptoms of congestive heart failure, or in the secondary outcomes including death from any cause and worsening of heart failure
  • 15. However…. • These studies enrolled predominantly older patients (average 70 y) • Most of whom had persistent AF and heart disease, • Follow-up extended over just a few years • Pts were at a stage where difficult to maintain sinus rhythm Hence : • Data don’t necessarily apply in young • Must not lose “window” of opportunity due to electrical and structural remodeling
  • 16. Hence…  Rate control may be reasonable initial therapy in older patients with persistent AF with mild symptoms  For younger individuals, especially those with paroxysmal lone AF, rhythm control may be a better initial approach.
  • 17. When to do Rate Control ?
  • 18. How to do long-term rate control
  • 19. How MUCH rate control ? < 80, 110 Exercise test if excessive heart rate is anticipated during More strict rate exercise Symptoms control Rate Control 24 h ECG for safety No or tolerable Accept lenient symptoms rate control resting<110/mt
  • 20. Rhythm Control Rhythm control therapy is reasonable to ameliorate symptoms, in paroxysmal/persistent AF
  • 21. When to do Rhythm Control ?
  • 22. AAD Therapy to maintain sinus rhythm in patients with recurrent paroxysmal or persistent atrial fibrillation. β-Blockers are recommended for prevention of adrenergic AF-I C & should be considered for rhythm (+ rate) control in a first episode of AF - IIa 2011 Writing Group Members et al. Circulation 2011;123:104-123 Copyright © American Heart Association
  • 23. Antiarrhythmic drugs v/s left atrial ablation for rhythm control in AF ESC 2012
  • 24. Catheter ablation for AF using the CARTO contact mapping system
  • 27. Recommendation for atrioventricular node ablation in AF patients Should be considered  When the rate cannot be controlled with pharmacological agents and  when AF cannot be prevented by antiarrhythmic therapy or is associated with intolerable side effects,  when direct catheter-based or surgical ablation of AF is not indicated, has failed, or is rejected. IIa Should be considered for patients with permanent AF and an indication for CRT (IIa) Should be considered for CRT nonresponders in whom AF prevents effective biventricular stimulation and amiodarone is ineffective or contraindicated- IIa • In patients with any type of AF and severely depressed LV function biventricular stimulation should be considered after AV node ablation.
  • 28. Summary- management of patients with recurrent paroxysmal AF Recurrent Paroxysmal AF Minimal or no Disabling symptoms symptoms in AF Anticoagulation Anticoagulation and rate control* and rate control as needed as needed No drug for AAD therapy * prevention of AF AF ablation if AAD treatment fails
  • 29. Summary- management of patients with recurrent persistent or permanent AF Recurrent Persistent AF Permanent AF Minimal or no Disabling Anticoagulation and rate symptoms control* as needed symptoms in AF Anticoagulation and Anticoagulation and rate control* as rate control needed AAD drug therapy Electrical cardioversion as needed Continuous anticoagulation as needed and therapy to maintain sinus rhythm * Consider ablation for severely symptomatic recurrent AF after failure of greater than or equal to 1 AAD plus rate control

Editor's Notes

  1. These therapeutic goals need to be pursued in parallel, especially upon the initial presentation of newly detected AF.These therapies may already alleviate symptoms, but symptom relief may require additional rhythm control therapy by cardioversion, antiarrhythmic drug therapy, or ablation therapy An irregular rhythm and a rapid ventricular rate in AF can cause symptoms including palpitations, dyspnoea, fatigue, and dizziness.Adequate control of the ventricular rate may reduce symptoms and improve haemodynamics, by allowing enough time for ventricularfilling and prevention of tachycardiomyopathy
  2. Requirement of OAC for 45 day, DAPT for 1 yr and life long aspirin in the PROTECT AF trialAdverse events with procedurebased on expert consensus only.
  3. Requirement of OAC for 45 day, DAPT for 1 yr and life long aspirin in the PROTECT AF trialAdverse events with procedurebased on expert consensus only.